Clinical Trial

STunning in Acute Myocardial Infarction - BAS

Study acronym: STAMI-BAS
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-08-16; most recent amendment 2025-06-24.
Status change: Not Yet Recruiting → Recruiting 2025-03-26
Trial Details
NCT Number NCT06562582
Lead Sponsor Vastra Gotaland Region
Conditions Myocardial Infarct
Enrollment 120 participants
Start Date 2025-01-06
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27